TARGETTING AGENTS

Derivatives of the alpha -MSH4-10 analogue polypeptide [Nle , Asp , D-Phe , Lys ] alpha -MSH4-10-NH2 bearing a targetted moiety such as a diagnostic or therapeutic radionuclide or a chelating group such as DTPA are useful in diagnosis and treatment of melanoma.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DAVID ROY BARD, CLIVE GRAHAM KNIGHT, DAVID PETER PAGE-THOMAS
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Derivatives of the alpha -MSH4-10 analogue polypeptide [Nle , Asp , D-Phe , Lys ] alpha -MSH4-10-NH2 bearing a targetted moiety such as a diagnostic or therapeutic radionuclide or a chelating group such as DTPA are useful in diagnosis and treatment of melanoma.